alter polymorphonuclear leukocyt glycogen metabol glucos uptak dialysi patient human polymorphonuclear leukocyt pmn extracorpor circul indic pmn activ glycogen-degrad enzym phosphorylas unknown dialysi therapi pmn carbohydr metabol pmn healthi control subject patient continu ambulatori periton dialysi capd patient regular hemodialysi therapi rdt end hemodialysi HD treatment dialyz polysulfon polymethylmethacryl pmma nifedipin nif HD pmma patient dose micrograms/kg bodi hour glycogen activ glycogen synthetas phosphorylas activ inact form enzym glucos uptak stimul chemotact peptid fmlp pmn HD pmma signific increas pmn phosphorylas activ minut start HD HD polysulfon activ form glycogen-degrad enzym pmn HD pmma activ i-form glycogen synthetas polysulfon glycogen synthetas nif phosphorylas activ HD pmma pmn glycogen content glucos uptak HD polysulfon pmma pmn glycogen content activ glycogen synthetas glucos uptak capd patient healthi control data HD pmma pmn glycogenolysi effect calcium channel blocker pmn glycogen content rdt capd patient healthi control due inhibit glycogen synthesi elimin dialyz factor pmn glycogen synthesi glucos uptak 